Kirk Johnson is the Sant Director of the Smithsonian’s National Museum of Natural History where he oversees the world’s largest natural history collection. The museum hosts more than 6 million ...

Johnson & Johnson is a leading healthcare company that sells pharmaceutical products, medical devices, supplies, and equipment worldwide. The healthcare industry doesn't stop for recessions or ...

Christopher K. Johnson is a senior fellow at CSIS. An accomplished Asian affairs specialist, Mr. Johnson spent nearly two decades serving in the U.S. government’s intelligence and foreign affairs ...

Don Johnson was one of the biggest icons of the '80s thanks to his role on "Miami Vice," but that fame came with a downside. "For a long time, I couldn’t even go anywhere," Johnson told People ...

Both these factors can be tied in part to J&J’s strong presence in the consumer sector – but behind household name products is a ... s long and varied history. Johnson & Johnson was founded ...

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...

Don Johnson was one of the biggest icons of the ’80s thanks to his role on “Miami Vice,” but that fame came with a downside. “For a long time, I couldn’t even go anywhere,” Johnson ...

Johnson & Johnson JNJ said Tuesday the U.S. Food and Drug Administration has approved a combination treatment for a type of lung cancer that’s the first chemotherapy-free regimen. The FDA has ...

Earnings Report 2.176 USD Q3 2024 Earnings Release 10/15/2024 Earnings Report 2.301 USD Q4 2024 Earnings Release 01/28/2025 Earnings Report 2.678 USD Q1 2025 Earnings Release 04/22/2025 Earnings ...

Carolyn Johnson is a science reporter. She previously covered the business of health, the pharmaceutical industry and the affordability of health care to consumers. Before coming to the Post ...

The defeat of the bill puts Republican divisions on full display, but it also creates an opportunity for Speaker Mike Johnson to pivot to a Plan B as a shutdown looms, though the speaker has not yet ...

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other cheap pharmaceutical stocks. The pharmaceutical industry is one of the most interesting ...